Cardiology
Outcomes Research in Review
Use of Hybrid Coronary Revascularization in Patients with Multivessel Coronary Artery Disease
Clinical Review
Calculating Risk for Poor Outcomes After Transcatheter Aortic Valve Replacement
FDA/CDC
FDA grants Priority Review to Vascepa for cardiovascular risk reduction
The Food and Drug Administration has granted a Priority Review to the supplemental new drug application for icosapent ethyl (Vascepa).
News
Cholesterol guideline: Risk assessment gets personal
A 2018 AHA/ACC document promotes “careful adherence to lifestyle recommendations at an early age [to] decrease the need for preventive drug...
FDA/CDC
FDA: Faulty hematology analyzers face class I recall
Beckman Coulter has released a software patch it hopes may help warn operators of inaccurate results, but this fix has not been evaluated by the...
News
Diabetes, hypertension remission more prevalent in adolescents than adults after gastric bypass
However, their rate of abdominal reoperations was significantly higher than that of adults during a 5-year follow-up.
Conference Coverage
SCAI releases first definition of cardiogenic shock
LAS VEGAS –
Conference Coverage
CABANA: Heart failure patients got biggest bang from AFib ablation
SAN FRANCISCO – A CABANA trial subanalysis showed that patients with any heart failure type had the greatest benefit from AFib catheter ablation...
News
BMI in male teens predicts cardiomyopathy risk
The hazard ratio for dilated cardiomyopathy in adulthood was 1.38 when adolescent body mass index was 22.5-25.0 kg/m2 – and rose to 8....
News
AFib on the rise in end-stage COPD patients hospitalized for exacerbations
The prevalence of AFib among patients with end-stage COPD on home oxygen who were admitted with COPD exacerbations increased from 12.9% in 2003 to...